Orion Oyj Class A · OMXHEX:ORNAV
Orion Oyj Class A — Investor Day (May 2023)
9 slides from Orion Oyj Class A's investor day presentation, May 25, 2023
Slide 1: Animal Health Business Division
Animal Health Business Division Niclas Lindstedt, Senior Vice President
Slide 2: Disclaimer
Disclaimer This presentation contains forward-looking statements which involve risks and uncertainty factors. These statements are not based on historical facts but relate to the Company’s future activities and performance. They include statements about future strategies and anticipated benefits of
Slide 3: Overview of Animal Health Business Division
Overview of Animal Health Business Division 120 99 Orion Animal Health after the acquisition of Inovet in 2022 100 +103% EUR million 80 Q1'22 60 Q1'23 40 27 Broader Wider 2022 20 13 product geographic Critical size 0 offering presence Net sales Sales split in Q1’23 by product categories Net sales sp
Slide 4: Our business model has changed
Our business model has changed Investment in new markets Own sales New innovations ANIMAL HEALTH Partnerships Orion Pharma Animal Out- Health Export licensing Out- In-licensed licensed products products R&D will diversify its In- Generic licensing competences New Pro- Services innovations Health 4 C
Slide 5: Productive R&D is one of the cornerstones of success
Productive R&D is one of the cornerstones of success Geepenil Comforion Benzorion Kefavet 5 CMD 25 May 2023 © Orion Corporation
Slide 6: Building blocks for growth – Animal Health
Building blocks for growth – Animal Health In-licensing Make the most Companion animals Geographic out of (focus in pain, sedation, anesthesia, expansion Orion + Inovet behavior) Livestock (focus in poultry, swine and ruminants) 6 CMD 25 May 2023 © Orion Corporation
Slide 7: Making most out of Orion + Inovet – a step-change
Making most out of Orion + Inovet – a step-change Cross-selling • Focus on customers • Utilize own and products production • Current products to • Optimize structure • Wider geographic new markets and processes presence • Larger customer base Integration New products 7 CMD 25 May 2023 © Orion Corpor
Slide 8: Key takeaways
Key takeaways 1.Inovet acquisition forms a good basis to grow further 2.Larger size (both geographical and product portfolio wise) creates more opportunities for new products and services a) Through own R&D b)Through in-licensing 8 CMD 25 May 2023 © Orion Corporation
Slide 9: We provide meaningful, compassionate animal health care
We provide meaningful, compassionate animal health care that prioritizes the well-being of animals and their caregivers